🇺🇸 FDA
Patent

US 9636305

Antiemetic extended release solid dosage forms

granted A61KA61K31/4178A61K9/2013

Quick answer

US patent 9636305 (Antiemetic extended release solid dosage forms) held by RedHill Biopharma Ltd. expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4178, A61K9/2013, A61K9/2054, A61K9/209